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Edited by Lukas HuberAbstract 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) uptake and reduction is widely used to evaluate
cell proliferation and viability. MTT is taken up by the cells
through endocytosis. We ﬁnd that ouabain (1–200 nM) inhibits
MTT reduction in human umbilical vein endothelial cells
(HUVEC) without aﬀecting cell viability. Ouabain does not
inhibit MTT reduction when cell lysates substituted for the intact
cells. Disruption of caveolae by cholesterol depletion, completely
prevents the eﬀect of ouabain. Treatment of HUVEC with
Src inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo
[3,4-d]pyrimidine partially abrogates the inhibitory eﬀect of oua-
bain. The data suggest that ouabain interaction with caveolar
Na/K-ATPase inhibits MTT endocytosis through the activation
of signaling proteins such as Src kinase.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Recently it has been shown that Na/K-ATPase, in addition
to its ion pumping function, may act as a signal transducer,
inducing the assembly of multiple protein complexes that
transmit signals to diﬀerent intracellular compartments in-
volved in the control of cell proliferation and growth or in
the protection against apoptotic stimuli [1–3]. The interaction
of ouabain with Na/K-ATPase induces a rapid activation of
Src, a tyrosine kinase located in the cytoplasmic side of the
plasma membrane. Src activation acts on the epidermal growth
factor receptor (EGFR), which recruits the adaptor protein
Shc and transmits the signal to the Ras-Raf-MAPKs cascade.Abbreviations: bFGF, basic ﬁbroblast growth factor; EGFR, epidermal
growth factor receptor; ERK, extracellular signal-regulated kinase;
FBS, fetal bovine serum; HUVEC, human umbilical vein endothelial
cells; MbCD, methyl b-cyclodextrin; MTT, 3-(4,5-dimethylthiazol-2-y-
l)-2,5-diphenyltetrazolium bromide; PI3K, phosphatidylinositol 3
kinase; PP2, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]py-
rimidine
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doi:10.1016/j.febslet.2006.04.040Src activation is also involved in the ouabain-induced increase
of reactive oxygen species and the activation of protein kinase
C [1]. Furthermore, it has been demonstrated that the interac-
tion of Na/K-ATPase with neighbouring membrane proteins
takes place in the caveolae, invaginations of the plasma mem-
brane enriched in cholesterol, glycosphingolipids, sphingomy-
elin and the protein caveolin [4,5].
We have recently reported that ouabain has an antiapoptotic
eﬀect on human umbilical vein endothelial cells (HUVEC)
through the activation of phosphatidylinositol 3 kinase
(PI3K) and extracellular signal-regulated kinases (ERKs) [3].
In the course of this study, we observed that ouabain-treated
HUVEC show a decrease in 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction that is not
associated with a decrease in cell viability, as assessed by try-
pan blue exclusion assay. This raised the question as to
whether ouabain would aﬀect MTT assay. MTT reduction is
considered to be indicative of cellular metabolic activity and
its measure is widely used to evaluate cell proliferation and via-
bility [6]. MTT is taken up by cells through endocytosis and re-
duced to formazan primarily in the endosome/lysosome
compartment by a N-ethylmaleimide-sensitive ﬂavin oxi-
dase(s). Formazan is then transported to the cell surface by
exocytosis where it appears as a crystalline product [6]. The
present study has been designed to investigate the eﬀect of
ouabain on the endocytosis of MTT by HUVEC. Our data
show that ouabain inhibits MTT uptake without aﬀecting its
reduction.2. Materials and methods
2.1. HUVEC isolation and culture
HUVEC were isolated in our laboratory from human umbilical cord
according to Jaﬀe et al. [7] as described previously [8]. The cells col-
lected were grown in complete medium M199 containing 10% fetal bo-
vine serum (FBS), 5 ng/ml basic ﬁbroblast growth factor (bFGF),
25 U/ml heparin, 4 mM L-glutamine, 100 U/ml penicillin-G, 100 U/
ml streptomycin. HUVEC were used from passage two to six. Exper-
iments were performed in complete medium M199 without bFGF.
2.2. Other cell lines
ECV304 (human urinary bladder carcinoma cell line) and A7r5 (cell
line of vascular smooth muscle cells from rat embryo aorta) were from
IZS (Brescia, Italy). ECV304 cells were grown in M199 containing 10%
FBS, 2 mM L-glutamine and antibiotics. A7r5 were grown in DMEM
containing 10% FBS, 2 mM L-glutamine and antibiotics. Before theblished by Elsevier B.V. All rights reserved.
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were performed in serum-free medium plus 0.1% bovine serum albu-
min.2.3. MTT assay
HUVEC (20000 cells/well), ECV304 (20000 cells/well) and A7r5
(10000 cells/well) were plated in 96-well culture plate and incubated
with or without ouabain at the indicated concentrations and time.
Four hours before the end of the treatment 10 ll of stock solution of
MTT (12 mM in phosphate buﬀered saline) was added to each well.
At the end of the treatment the incubation medium was removed
and the formazan crystals were dissolved in 100 ll of solution of
DMSO. MTT reduction was quantiﬁed by measuring the light absor-
bance with a multilabel plate counter (VICTOR2 – Wallac) at 570–
630 nm. Background absorbance from control wells (media without
cells) was subtracted.2.4. Trypan blue exclusion assay
Cells were incubated with or without ouabain at the indicated con-
centrations for 24 h. At the end of the treatment, cells were harvested
and trypan blue was added to the cell suspension to a ﬁnal concentra-
tion of 0.04%. Cells excluding trypan blue (viable cells) and cells per-
meable to trypan blue (dead cells) were counted under the
microscope with a Burker hemocytometer.2.5. MTT reduction in cell lysates
MTTreduction curve byHUVEC lysates:HUVEC (1 · 106 cells/dish)
were seeded in a 10 cm-petri dish. The day after cells were lysed in 400 ll
lysis buﬀer (100 mM NaCl, 10 mM Tris, pH 7.5, 1 mM EDTA, 0.01%
Triton X-100, protease inhibitors cocktail) at 4 C. The cells lysate
(80 ll) was then incubated with various concentrations of MTT (ﬁnal
0.1, 0.5, 1, 5 mM) for 2 h at 37 C. MTT reduction by HUVEC lysates
was determined also in the presence of 100 nM ouabain.
MTT reduction by lysates of ouabain treated HUVEC: 700000 cells/
dish were seeded in a 5 cm-petri dish. The day after the cells were incu-
bated in complete medium (without bFGF) in the presence or in the
absence of 100 nM ouabain for 4 h. At the end of the treatment the
cells were lysed with 150 ll of lysis buﬀer at 4 C, then 110 ll of cell
lysate was incubated with 1 mMMTT for 2 h at 37 C. MTT reduction
by HUVEC lysates was normalized for the protein content.
2.6. Cholesterol depletion
Cholesterol depletion was carried out by treatment of the cells with
methyl b-cyclodextrin (MbCD), as described by Wang et al. [5] and
MTT assay was then performed. Brieﬂy, HUVEC, seeded in 96-well
plates, were incubated in M199 containing 0.1% MbCD for 30 min
at 37 C. The cells were then accurately washed and incubated for
5 h with or without 100 nM ouabain in complete M199 (without
bFGF). MTT assay was performed as described above.
2.7. Chemicals
Cell culture media, FBS, bFGF, MbCD, ouabain, PD98059, and
wortmannin were from Sigma. Type 2 collagenase was purchased from
Worthington. 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-
d]pyrimidine (PP2) was from Calbiochem. PD98059, PP2 and wort-
mannin were dissolved in dimethylsulfoxide (DMSO). MbCD was dis-
solved in the cell culture medium and used directly.
2.8. Statistical analysis
Results are presented as means ± standard error of the mean (S.E.).
Statistical signiﬁcance of the diﬀerences between experimental groups
were calculated by one-way ANOVA followed by the Dunnett’s or
Bonferroni’s Multiple Comparison Test.3. Results
3.1. MTT reduction and cell proliferation
The treatment of HUVEC with nanomolar concentrations
of ouabain for 24 h induced a signiﬁcant decrease in MTTreduction (Fig. 1A). This decrease was not associated with a
reduction of cell viability as determined by the trypan blue
exclusion assay (Fig. 1B). Rather, ouabain produced a slight
increase in cell viability (cells excluding trypan blue) without
inducing an increase in HUVEC proliferation since changes
in total cell number (viable plus non-viable cells) were not sig-
niﬁcant after ouabain treatment: 61000 ± 4200 for control cells
and 63250 ± 2500 for 100 nM ouabain treated cells (P > 0.05,
n = 4). Ouabain produced the same eﬀects on MTT reduction
and cell viability in HUVEC incubated in serum-free medium
for 24 h (not shown). These observations are in accord with the
protective eﬀect of ouabain against growth factor and serum
deprivation in HUVEC previously reported by our group [3].
Shorter treatments with ouabain (5 and 8 h) also induced a sig-
niﬁcant decrease in MTT reduction (Fig. 1C and D).
To ascertain whether the eﬀect of ouabain was speciﬁc for
endothelial cells, we tested ouabain on ECV304, a human uri-
nary bladder carcinoma cell line, and A7r5, a vascular smooth
muscle cell line from rat embryo aorta. Unlike HUVEC,
ECV304 showed a concentration-dependent decrease of MTT
reduction associated with a loss of cell viability after a 24-h
treatment with ouabain (Fig. 2A and B). In contrast, when oua-
bain was added to A7r5 cells, the cell number and the MTT
reduction were increased after 24 h treatment (Fig. 2C and
D). This observation is in agreement with the proliferative eﬀect
of ouabain reported in vascular smooth muscle cells, including
the A7r5 cells [9]. These data suggest that the action of ouabain
on MTT uptake and cell proliferation is cell-type speciﬁc.3.2. MTT reduction in HUVEC lysates
To test whether the eﬀect of ouabain in HUVEC was due to
an inhibition of the enzyme(s) involved in MTT reduction, we
studied the eﬀect of 100 nM ouabain on MTT reduction by
HUVEC lysates. We also determined MTT reduction of ly-
sates obtained from HUVEC pretreated with 100 nM ouabain
for 4 h. As shown in Fig. 3, ouabain did not inhibit MTT
reduction in the two experimental conditions indicating that
the eﬀect was likely due to the inhibition of MTT endocytosis.3.3. Eﬀect of PI3K and ERK inhibition on the action of ouabain
It has been shown that activation of PI3K regulate vesicular
traﬃcking including endocytosis [10]. Moreover, PI3K inhibi-
tion with wortmannin reduces the ouabain-induced endocytosis
of Na/K-ATPase in pig renal proximal tubule cells (LLC-PK1
cells) [11]. Since ouabain is able to induce PI3K and ERKs
activation in HUVEC [3], we investigated if the eﬀect of ouabain
on MTT uptake is mediated by these two kinases. Pretreatment
of HUVEC with 100 nM wortmannin (inhibitor of PI3K) or
25 lM PD98059 (inhibitor of ERK kinase) for 30 min did not
aﬀect MTT reduction in control cells and did not counteract
the inhibition of MTT reduction induced by ouabain (not
shown).3.4. Inﬂuence of cholesterol depletion
It has been reported that caveolar Na/K-ATPase forms a
signaling complex transmitting the ouabain inﬂuence inside
the cells and that disruption of caveolae by cholesterol deple-
tion abolishes this role of Na/K-ATPase [4]. To investigate
whether the ouabain-induced inhibition of MTT reduction is
mediated by caveolar Na/K-ATPase, MTT assay was per-
formed after cholesterol depletion of HUVEC with MbCD.
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Fig. 2. Eﬀect of ouabain on MTT reduction and cell viability in A7r5 and ECV304. A7r5 were incubated with ouabain (10–1000 nM) for 24 h, (A)
MTT reduction or (B) total cell number and trypan blue exclusion were determined (cells permeable to trypan blue were about 10% in each
condition). ECV304 were incubated with ouabain (1–1000 nM) for 24 h, MTT reduction (C) or the number of cells excluding trypan blue (D) were
measured. Data are expressed as means ± S.E. of three experiments performed in sixtuplicate (A, C) and three experiments performed in duplicate (B,
D). **P < 0.01 (vs. none).
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Fig. 1. Eﬀect of ouabain on MTT reduction and cell viability measured by trypan blue exclusion in HUVEC. HUVEC were incubated with ouabain
(1–200 nM). MTT reduction after 24 h (A), 5 h (C) and 8 h (D). (B) Trypan blue exclusion after 24 h incubation. MTT was added in the last 4 h of
incubation. Data are expressed as means ± S.E. of three experiments performed in sixtuplicate (A, C, D) and four experiments performed in duplicate
(B). *P < 0.05 (vs. none), **P < 0.01 (vs. none).
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Fig. 3. MTT reduction by HUVEC lysates. (A) HUVEC were plated in 10 cm-dish and at conﬂuence were lysed as described in Section 2; cell lysates
were incubated for 2 h at 37 C with increasing concentrations of MTT in the presence or in the absence of 100 nM ouabain. (B) HUVEC were plated
in 5 cm-petri dish and incubated with or without 100 nM ouabain for 4 h, then the cells were lysed and incubated for 2 h at 37 C in the presence of
1 mM MTT. Absorbance of the formazan product was quantiﬁed with a multilabel plate counter and normalized for protein content of cell lysate.
Data are the average of two experiments (A) and three experiments performed in duplicate (B).
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Fig. 4. Eﬀect of cholesterol depletion on the ouabain-induced inhibi-
tion of MTT reduction. Where indicated the cells were treated with
0.1% MbCD for 30 min as described in Section 2. HUVEC were
incubated with or without 100 nM ouabain for 5 h. MTT was added in
the last 4 h of incubation. Data are expressed as means ± S.E. of ﬁve
experiments performed in sixtuplicate. ***P < 0.001 (vs. undepleted
control cells), ###P < 0.001 (vs. undepleted cells treated with ouabain).
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Fig. 5. Eﬀect of Src-kinase inhibition on the ouabain-induced inhibi-
tion of MTT reduction. Where indicated the cells were pretreated for
30 min with 50 lM PP2. HUVEC were then incubated with or without
100 nM ouabain for 5 h. PP2 was also included during the experiment.
MTT was added in the last 4 h of incubation. Data are expressed as
means ± S.E. of ﬁve experiments performed in sixtuplicate. **P < 0.01
(vs. control without PP2), ##P < 0.01 (vs. ouabain without PP2).
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100 nM ouabain was completely abolished by cholesterol
depletion (Fig. 4). This result indicates that caveolar integrity
is essential for the action of ouabain.
3.5. Eﬀect of Src kinase inhibition
It has been shown that activation of the signaling pathways
induced by ouabain Na/K-ATPase interaction is mediated by
Src activation [1,4,5]. To ascertain whether the activation of
Src kinase is required for the ouabain-induced inhibition of
MTT reduction, HUVEC were pretreated with the Src kinase
inhibitor PP2 (50 lM) for 30 min. As shown in Fig. 5, PP2
attenuated the ouabain-induced inhibition of MTT reduction
suggesting that activation of Src, at least partially, is involved
in the action of ouabain.4. Discussion
Previous studies on the interaction of MTT with mammalian
cells propose that this water soluble tetrazolium salt is taken
up into the cells by endocytosis, probably ﬂuid-phase endocy-
tosis [6]. Subsequently, the reduction of MTT to formazan is
primarily performed in the endosome/lysosome compartment.
The exocytosis of formazan-containing vesicles gives rise to
needle-like formazan crystals at the cell surface [6].
The present paper shows that ouabain causes a signiﬁcant
inhibition of MTT reduction in HUVEC without aﬀecting cell
viability. This eﬀect is cell-speciﬁc as it is not observed in other
cells such as ECV304 and A7r5. The eﬀect of ouabain on the
reduction of MTT in HUVEC is not due to the inhibition of
the intracellular enzymes involved in the metabolism of this
dye. Rather, it seems likely that the drug inhibits the endocy-
tosis and the movements of MTT inside the cells. This conclu-
sion is supported by the lack of ouabain eﬀect in cell lysates
and by the full reducing activity of lysates obtained from the
ouabain-treated HUVEC.
In recent years it has been suggested that Na/K-ATPase may
function as a signal transducer converting extracellular stimuli,
such as non-toxic concentrations of ouabain, into the activa-
tion of multiple signaling pathways functionally interrelated
L. Trevisi et al. / FEBS Letters 580 (2006) 2769–2773 2773[1]. The signaling role of Na/K-ATPase occurs within the cav-
eolae, plasma membrane microdomains involved in endocyto-
sis and signaling processes. The sequence driven by the
ouabain-Na/K-ATPase interaction involves the Src-dependent
transactivation of EGFR, yielding the activation of ERK as a
ﬁnal event [1]. In endothelial cells caveolae are abundant and
have been also implicated in vesicular traﬃcking (endocytosis,
transcytosis and protocytosis) [12]. In agreement, our data
demonstrate that caveolar integrity is essential to the eﬀect
of ouabain since cholesterol depletion of HUVEC with MbCD
completely prevents the inhibition of MTT reduction. Choles-
terol depletion has been shown to disrupt caveolae and to
prevent the ouabain-induced formation of Na/K-ATPase-
Src-caveolin complex. The formation of this complex is in-
volved in Na/K-ATPase endocytosis induced by ouabain, thus
suggesting a link between ouabain-induced signaling and endo-
cytosis [13]. In agreement with the involvement of Src in the
action of ouabain on MTT endocytosis we observed that the
Src-kinase inhibitor PP2 attenuated the ouabain-induced inhi-
bition. In contrast, the inhibitors of PI3K and ERK did not
change the eﬀect of ouabain. It remains to be ascertained
whether the activation of the signalling pathways involved in
the eﬀect of ouabain in HUVEC is dependent on the inhibition
of sodium pump activity, although the concentrations of oua-
bain used in our experiments only produces a slight inhibition
of the Na/K-ATPase activity in HUVEC [14].
It has been shown that ouabain activates Src via caveolar
Na/K-ATPase in A7r5 cells [15,16], however we found that
ouabain does not aﬀect MTT assay in this cell line. Our study
does not provide an explanation for this diﬀerence, but it could
be hypothesized that ouabain-Na/K-ATPase interaction could
regulate some mechanism of vesicular traﬃc that is important
or speciﬁc for endothelial cells. Moreover, the eﬀect of ouabain
on cell viability is diﬀerent in the two cell lines, the drug is anti-
apoptotic in HUVEC and increases cell proliferation in A7r5.
These observations, together with the data obtained by others
in several cell lines indicate that, although ouabain interaction
with Na/K-ATPase triggers the same signalling pathways, the
ﬁnal eﬀects could be diﬀerent depending on the cell type.
Taken together these results indicate that in HUVEC the
interaction of ouabain with the caveolar Na/K-ATPase initi-
ates signaling pathways leading to the inhibition of MTT
endocytosis. Further studies are necessary to deﬁne the physi-
ological relevance of this eﬀect.Acknowledgments: We thank A. Bruni for helpful comments. Sup-
ported by Ministero dell’Istruzione Universita` e Ricerca, Coﬁn.
2003064224-002 (to S.L.).References
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